YLL006W-A Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Target Specificity

The YLL006W-A antibody targets the protein encoded by the YLL006W-A gene in Saccharomyces cerevisiae. This gene is annotated as a hypothetical open reading frame (ORF) with limited functional characterization. The antibody is produced by immunizing rabbits with recombinant YLL006W-A protein, enabling specific recognition of this antigen in immunoassays .

Role of YLL006W in Yeast Biology

While the YLL006W-A protein’s function remains uncharacterized, genomic studies associate it with mitochondrial processes. Large-scale mitochondrial proteome profiling efforts, such as the "Y3K" project, have identified YLL006W as a target strain for systematic functional annotation, suggesting potential roles in oxidative phosphorylation or metabolite biosynthesis .

Utility in Protein Detection

The YLL006W-A antibody enables:

  • Localization studies: Tracking YLL006W-A expression under varying metabolic conditions.

  • Protein interaction assays: Identifying binding partners in yeast proteomic screens.

  • Validation of gene deletion strains: Confirming the absence of YLL006W-A in mutant yeast lines .

Limitations and Future Directions

  • Specificity constraints: Cross-reactivity with homologous yeast proteins cannot be ruled out without further validation.

  • Functional insights: The antibody’s utility depends on advancing research into YLL006W-A’s biological role, which remains a gap in mitochondrial biochemistry .

References

- Hoelzel Biotech. (2025). YLL006W-A Antibody Product Specifications.
- Stefely, J. A., & Pagliarini, D. J. (2025). Biochemical Functions of Mitochondrial ADCK3 and Other Uncharacterized Proteins. University of Wisconsin-Madison.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLL006W-AUncharacterized protein YLL006W-A antibody
Target Names
YLL006W-A
Uniprot No.

Target Background

Database Links
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is YLL006W-A and what is its function in yeast models?

YLL006W-A is a yeast gene identified in Saccharomyces cerevisiae. While the search results do not specifically detail the function of YLL006W-A, they demonstrate the convention for yeast gene nomenclature, where genes are typically denoted with italicized capital letters (e.g., CKA1) . YLL006W-A would follow this convention, representing a specific open reading frame (ORF) in the yeast genome. When studying this gene's function, researchers typically employ deletion mutants (denoted with the delta symbol, e.g., cka2Δ) to understand how loss of the gene affects cellular processes . Analysis of phenotypic changes in such deletion mutants can reveal involvement in specific cellular pathways, similar to how researchers have identified roles for genes like CKA2 in metal ion toxicity mechanisms.

How should researchers validate the specificity of YLL006W-A antibodies?

Validation of antibody specificity for yeast proteins requires multiple methodological approaches:

  • Genetic controls: Test antibody reactivity against wild-type and YLL006W-A deletion mutants to confirm specificity

  • Cross-reactivity assessment: Evaluate binding to related yeast proteins to ensure target specificity

  • Western blot analysis: Perform immunoblotting with appropriate positive and negative controls

  • Immunoprecipitation verification: Confirm that the antibody can specifically capture the YLL006W-A protein product

The scientific rigor demonstrated in metal ion toxicity studies, where researchers verified CK2 involvement through both genetic and pharmacological approaches (e.g., TBB inhibitor studies), exemplifies how validation should be conducted .

Which experimental techniques are most suitable for detecting YLL006W-A expression in different yeast growth phases?

For monitoring YLL006W-A expression across different growth phases, researchers should consider:

  • Quantitative PCR (qPCR): For measuring transcript levels, similar to techniques used in metal toxicity studies

  • Western blotting: For protein level quantification with appropriate normalization to housekeeping proteins

  • Fluorescent protein tagging: Creating fusion proteins for live-cell imaging of expression dynamics

  • Flow cytometry: For population-level analysis of protein expression in yeast cultures

The selection of technique should be guided by experimental questions. For instance, if investigating YLL006W-A's response to environmental stressors (like metal ions), time-course analyses similar to those conducted at various time points (T0, T16, T20, T24) in metal toxicity studies would be appropriate .

How might YLL006W-A be involved in metal ion homeostasis pathways based on knowledge of related yeast genes?

While specific information about YLL006W-A's role in metal ion homeostasis is not directly provided in the search results, we can infer potential methodologies based on similar studies:

Research into protein kinase CK2 subunits demonstrated distinct roles in metal ion toxicity. For example, CKA2 deletion conferred resistance to Al³⁺ and Zn²⁺, with ICP-MS analysis showing that cka2Δ exhibited 52-85% reduction in Al³⁺ content compared to wildtype . To investigate YLL006W-A's potential involvement in metal homeostasis, researchers should:

  • Generate YLL006W-A deletion mutants and assess growth under various metal stress conditions

  • Perform ICP-MS quantification of intracellular metal content in wildtype versus deletion strains

  • Create double deletion mutants with known metal homeostasis genes to identify genetic interactions

  • Employ transcriptomics to determine if YLL006W-A expression changes in response to metal exposure

This methodological approach parallels how researchers uncovered CKA2's role in Al³⁺ uptake independent of other CK2 subunits .

What methodologies can address potential functional redundancy between YLL006W-A and related genes?

Addressing functional redundancy requires systematic approaches:

  • Generation of multiple deletion mutants: Create single, double, and triple mutants with genes suspected of redundancy

  • Phenotypic profiling: Assess growth characteristics under various stress conditions (e.g., metal ions, oxidative stress)

  • Pharmacological inhibition: Combine genetic deletion with chemical inhibitors to block potentially compensating pathways

  • Rescue experiments: Test if overexpression of related genes can complement YLL006W-A deletion phenotypes

The approach used to investigate CK2 function provides a methodological template: researchers created double deletion mutants (CKA2 with either CKB1 or CKB2) and combined this with CK2 inhibition using TBB to reveal that CKA2's role in Al³⁺ toxicity was independent of other CK2 subunits, while its role in Zn²⁺ response involved the remaining CK2 complex .

How can antibody-based approaches be optimized for studying YLL006W-A interactions with metal transporters?

Optimizing antibody-based approaches for studying protein-metal transporter interactions requires:

  • Co-immunoprecipitation optimization: Adjust buffer conditions to preserve weak or transient interactions

  • Proximity labeling techniques: Employ BioID or APEX2 fusion proteins to identify proximal interacting partners

  • In situ crosslinking: Use membrane-permeable crosslinkers to capture transient interactions before cell lysis

  • Fluorescence resonance energy transfer (FRET): Develop fluorescently tagged proteins to visualize interactions in live cells

These methodologies would be particularly relevant when investigating potential interactions between YLL006W-A and zinc transporters like ZNT or ZRT mentioned in the search results , which could reveal mechanistic insights into metal homeostasis pathways.

What are the critical controls needed when using YLL006W-A antibodies in chromatin immunoprecipitation (ChIP) experiments?

Critical controls for ChIP experiments with YLL006W-A antibodies include:

  • Input control: Unprocessed chromatin to normalize for DNA abundance

  • No-antibody control: Procedure without antibody to identify non-specific binding

  • Isotype control: Irrelevant antibody of same isotype to detect background binding

  • Gene deletion control: ChIP in YLL006W-A deletion strain to confirm specificity

  • Positive control regions: Known binding sites of similar transcription factors

  • Negative control regions: Genomic regions not expected to bind the protein

When designing experiments similar to those investigating metal-responsive elements (MREs) in metal toxicity studies , ensure appropriate positive controls for technical validation and biological interpretation.

How should researchers design experiments to study YLL006W-A's potential role in stress response pathways?

A comprehensive experimental design should include:

Experimental ApproachMethod DetailsControlsExpected Outcomes
Growth phenotypingSerial dilution spotting under various stressors (e.g., Al³⁺, Zn²⁺, H₂O₂)Wild-type strain, known stress-sensitive mutantsGrowth differences indicating pathway involvement
Gene expression profilingRNA-seq or qPCR of stress-responsive genesTime-point controls (T0, T4, T8, T12, T16) as used in metal toxicity studies Changes in expression patterns compared to wild-type
Protein localizationFluorescent tagging and microscopy before/after stressUnstressed cells, known stress-responsive proteinsSubcellular relocalization indicating functional response
Genetic interaction mappingSynthetic genetic array with known stress pathway mutantsSingle mutant controls, unrelated pathway mutantsGenetic interactions revealing pathway position

This approach parallels the time-course analyses and metal exposure methodologies used to characterize the role of CK2 subunits in metal toxicity .

How can researchers address potential cross-reactivity issues when using YLL006W-A antibodies in complex protein mixtures?

To minimize cross-reactivity concerns:

  • Pre-absorption: Incubate antibody with lysates from YLL006W-A deletion strains to remove cross-reactive antibodies

  • Epitope mapping: Identify unique epitopes in YLL006W-A for improved antibody design

  • Competition assays: Perform binding in presence of purified YLL006W-A protein to demonstrate specificity

  • Western blot optimization: Adjust blocking conditions and antibody concentrations to reduce background

  • Mass spectrometry validation: Confirm identity of immunoprecipitated proteins via MS analysis

These approaches ensure antibody specificity similar to how researchers validated CK2 subunit functions through complementary genetic and biochemical techniques .

What strategies can overcome limitations in detecting low-abundance YLL006W-A protein in different cellular compartments?

To enhance detection of low-abundance proteins:

  • Signal amplification: Implement tyramide signal amplification for immunofluorescence

  • Subcellular fractionation: Enrich for specific cellular compartments before analysis

  • Protein concentration: Use techniques like TCA precipitation to concentrate proteins

  • Advanced microscopy: Employ super-resolution techniques for better visualization

  • Targeted proteomics: Develop selected reaction monitoring (SRM) mass spectrometry assays

These approaches would be particularly valuable when studying proteins involved in metal homeostasis, which may exhibit compartment-specific functions as suggested by research on zinc transporters (ZNT, ZRT) and vacuolar membrane zinc transporters (ZRC1) .

How should researchers interpret contradictory results between antibody-based detection and genetic reporter assays for YLL006W-A?

When facing contradictory results:

  • Technical validation: Verify both antibody specificity and reporter construct functionality

  • Temporal considerations: Assess whether protein and transcript levels might be temporally uncoupled

  • Post-translational modifications: Determine if antibodies detect specific protein states that reporters cannot capture

  • Subcellular localization: Examine if differences reflect compartment-specific detection limitations

  • Systematic troubleshooting: Create a decision tree to methodically test each variable

The approach used to resolve apparently contradictory findings regarding CKA2's role in Al³⁺ versus Zn²⁺ resistance provides a template: researchers systematically employed double deletions, inhibitors, and direct metal measurements to reveal distinct mechanisms .

What statistical approaches are most appropriate for analyzing quantitative data from YLL006W-A antibody-based experiments?

Appropriate statistical analyses include:

  • For growth assays: Repeated measures ANOVA with post-hoc tests to assess significance across time points

  • For protein quantification: Non-parametric tests when assumptions of normality cannot be met

  • For microscopy data: Mixed-effects models to account for cell-to-cell variability

  • For metal content analyses: Similar to the ICP-MS approaches used in CK2 studies , paired t-tests or ANOVA with appropriate corrections for multiple comparisons

  • For time-course experiments: Time-series analysis methods accounting for temporal autocorrelation

Importantly, researchers should report standard error of the mean (SEM) as done in metal toxicity studies and implement appropriate statistical power calculations during experimental design.

How might YLL006W-A research contribute to understanding metal-related neurodegenerative disease mechanisms?

YLL006W-A research could provide insights into neurodegenerative disease mechanisms through:

  • Pathway conservation analysis: Identify human orthologs of YLL006W-A and associated proteins

  • Metal homeostasis mechanisms: Investigate shared pathways between yeast and neuronal cells

  • Disease model development: Use yeast as a simplified model for studying toxic metal accumulation

The search results highlight connections between metal dysregulation and neurodegenerative diseases: zinc affects Aβ precipitation in Alzheimer's disease, altered zinc binding in SOD1 is linked to ALS, and elevated zinc levels are observed in the substantia nigra in Parkinson's disease . YLL006W-A studies could potentially reveal novel mechanisms relevant to these conditions if it participates in conserved metal homeostasis pathways.

How can active learning approaches improve experimental design for studying YLL006W-A antibody interactions?

Active learning methodologies can enhance experimental efficiency:

  • Iterative experimental design: Begin with small-scale experiments and use results to guide subsequent larger studies

  • Machine learning prediction: Apply algorithms to predict potential interaction partners based on limited initial data

  • Library-on-library screening optimization: Implement approaches similar to those described for antibody-antigen binding prediction

As demonstrated in recent antibody research, active learning strategies reduced the number of required antigen mutant variants by up to 35% and accelerated the learning process by 28 steps compared to random approaches . Similar efficiency gains could be achieved in YLL006W-A interaction studies by strategically selecting experimental conditions based on preliminary results.

What interdisciplinary approaches can enhance understanding of YLL006W-A function in cellular metal homeostasis?

Effective interdisciplinary strategies include:

  • Computational structural biology: Predict protein-metal binding sites and interaction interfaces

  • Systems biology: Integrate transcriptomic, proteomic, and metabolomic data to place YLL006W-A in broader networks

  • Chemical biology: Develop small molecule probes to perturb YLL006W-A function

  • Evolutionary biology: Compare YLL006W-A across fungal species to identify conserved functional domains

These approaches mirror the integrative strategies used to study protein kinase CK2 in metal ion toxicity, where genetic, biochemical, and analytical methods were combined to elucidate specific mechanisms .

How can researchers effectively integrate antibody-based detection with other analytical techniques when studying YLL006W-A?

Integrative analytical approaches should:

  • Combine immunological and spectroscopic methods: Couple immunoprecipitation with ICP-MS to determine metal binding similar to approaches used in CK2 studies

  • Integrate genetic and proteomic analyses: Correlate phenotypes of deletion mutants with changes in protein abundance and modification

  • Merge structural and functional studies: Connect antibody epitope mapping with functional domains of the protein

  • Link temporal dynamics across methods: Align time-course data from different analytical platforms

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.